Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Androgen-induced gene 1 protein (AIG1) is a human protein encoded by the AIG1 gene, located on chromosome 6. It is a membrane-associated enzyme that hydrolyzes bioactive fatty acid esters of hydroxy fatty acids (FAHFAs), but does not act on other major lipid classes[2][3][4][5]. AIG1 is implicated in the regulation of long-chain fatty acid catabolism and has been shown to play a role in cellular signal transduction, specifically by modulating the NFAT signaling pathway[6]. Disease associations include amebiasis and myxosarcoma, and as an enzyme with unique lipid substrate specificity, it is a candidate for further study as a potential therapeutic target[2][6]. No known direct drug modulators or established clinical biomarkers are currently reported for AIG1.
Hydrolyzes (breaks down) fatty acid esters of hydroxy fatty acids (FAHFAs), modulates NFAT signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androgen-induced gene 1 protein (AIG1).